Surrogate Endpoints: CONSORT and SPIRIT Extensions.
作者信息
Schwendicke F, Jakubovics N S
机构信息
Clinic for Conservative Dentistry and Periodontology, Ludwig-Maximilians-University Munich, Munich, Germany.
School of Dental Sciences, Faculty of Medical Sciences, Newcastle University, Framlington Place, Newcastle upon Tyne, UK.
出版信息
J Dent Res. 2024 Nov;103(12):1163-1164. doi: 10.1177/00220345241275479. Epub 2024 Oct 6.
Abstract
摘要
相似文献
1
Surrogate Endpoints: CONSORT and SPIRIT Extensions.替代终点：CONSORT和SPIRIT扩展版
J Dent Res. 2024 Nov;103(12):1163-1164. doi: 10.1177/00220345241275479. Epub 2024 Oct 6.
2
Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE.用于具有替代主要终点的随机对照试验的 SPIRIT 和 CONSORT 扩展的制定方案：SPIRIT-SURROGATE 和 CONSORT-SURROGATE。
BMJ Open. 2022 Oct 11;12(10):e064304. doi: 10.1136/bmjopen-2022-064304.
3
Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol.范围界定和针对性综述，以支持具有替代主要终点的随机对照试验的 SPIRIT 和 CONSORT 扩展的制定：方案。
BMJ Open. 2022 Oct 13;12(10):e062798. doi: 10.1136/bmjopen-2022-062798.
4
Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.儿科和儿童健康临床试验方案和报告报告指南：SPIRIT-Children 和 CONSORT-Children 的研究方案。
Trials. 2024 Jan 30;25(1):96. doi: 10.1186/s13063-024-07948-7.
5
Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.儿科临床试验方案和报告中报告项目的建议与证据：两项系统评价
Trials. 2015 Sep 18;16:417. doi: 10.1186/s13063-015-0954-0.
6
SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol.早期阶段剂量发现临床试验的 SPIRIT 和 CONSORT 扩展：DEFINE（剂量发现扩展）研究方案。
BMJ Open. 2023 Mar 29;13(3):e068173. doi: 10.1136/bmjopen-2022-068173.
7
Reporting Guidelines for Clinical Trial Protocols and Reports of Implantable Neurostimulation Devices: Protocol for the SPIRIT-iNeurostim and CONSORT-iNeurostim Extensions.植入式神经刺激设备临床试验方案及报告的报告指南：SPIRIT-iNeurostim和CONSORT-iNeurostim扩展版方案
Neuromodulation. 2022 Oct;25(7):1045-1049. doi: 10.1016/j.neurom.2021.10.006. Epub 2021 Dec 18.
8
Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study.共识驱动的 SPIRIT 和 CONSORT 扩展在早期阶段剂量发现试验中的发展：DEFINE 研究。
BMC Med. 2023 Jul 5;21(1):246. doi: 10.1186/s12916-023-02937-0.
9
Transparent and complete reporting of surrogate endpoints in trials: the SPIRIT-Surrogate and CONSORT-Surrogate extensions.试验中替代终点的透明与完整报告：SPIRIT-替代终点和CONSORT-替代终点扩展版
Lancet. 2024 Jul 27;404(10450):322-324. doi: 10.1016/S0140-6736(24)01306-0. Epub 2024 Jul 11.
10
Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements.用于制定《SPIRIT 2024声明》和《CONSORT 2024声明》的方法。
J Clin Epidemiol. 2024 May;169:111309. doi: 10.1016/j.jclinepi.2024.111309. Epub 2024 Feb 29.
本文引用的文献
1
The OHStat Guidelines for Reporting Observational Studies and Clinical Trials in Oral Health Research: Manuscript Checklist.口腔健康研究中观察性研究和临床试验报告的 OHStat 指南：手稿清单。
J Dent Res. 2024 Oct;103(11):1076-1082. doi: 10.1177/00220345241247028. Epub 2024 Jul 12.
2
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration.随机对照试验报告中替代终点的报告（CONSORT-Surrogate）：扩展清单及解释和说明。
BMJ. 2024 Jul 9;386:e078524. doi: 10.1136/bmj-2023-078524.
3
Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration.随机对照试验方案中替代终点报告（SPIRIT-Surrogate）：扩展清单及说明和阐述。
BMJ. 2024 Jul 9;386:e078525. doi: 10.1136/bmj-2023-078525.
4
A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials.一项关于在干预性试验中替代终点使用的定义与解释的框架。
EClinicalMedicine. 2023 Oct 17;65:102283. doi: 10.1016/j.eclinm.2023.102283. eCollection 2023 Nov.
5
Patient Understanding of Oncology Clinical Trial Endpoints in Direct-to-Consumer Television Advertising.患者对直接面向消费者的电视广告中肿瘤临床试验终点的理解。
Oncologist. 2023 Jul 5;28(7):e542-e553. doi: 10.1093/oncolo/oyad064.
6
Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE.用于具有替代主要终点的随机对照试验的 SPIRIT 和 CONSORT 扩展的制定方案：SPIRIT-SURROGATE 和 CONSORT-SURROGATE。
BMJ Open. 2022 Oct 11;12(10):e064304. doi: 10.1136/bmjopen-2022-064304.
7
Clinically relevant outcomes in dental clinical trials: challenges and proposals.牙科临床试验中的临床相关结局：挑战与建议。
Braz Oral Res. 2020;34 Suppl 2:e073. doi: 10.1590/1807-3107bor-2020.vol34.0073. Epub 2020 Aug 7.
8
Reducing waste from incomplete or unusable reports of biomedical research.减少生物医学研究中不完整或无法使用的报告所造成的浪费。
Lancet. 2014 Jan 18;383(9913):267-76. doi: 10.1016/S0140-6736(13)62228-X. Epub 2014 Jan 8.
9
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.SPIRIT 2013 解释和说明：临床试验方案指南。
BMJ. 2013 Jan 8;346:e7586. doi: 10.1136/bmj.e7586.
10
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.CONSORT 2010解释与详述：平行组随机试验报告的更新指南
BMJ. 2010 Mar 23;340:c869. doi: 10.1136/bmj.c869.
Zotero 插件